Secondary antiphospholipid syndrome in systemic lupus erythematosus – screening, diagnosis and treatment methods
Authors:   “Carol Davila“ University of Medicine and Pharmacy, Bucharest, Romania, Mihailescu Andrei-Bogdan , Saulescu Ioana Cristina ,   “Carol Davila“ University of Medicine and Pharmacy, Bucharest, Romania,   “Sf. Maria“ Hospital, Internal Medicine and Rheumatology Department, Bucharest, Romania, Opris-Belinski Daniela ,   “Carol Davila“ University of Medicine and Pharmacy, Bucharest, Romania,   “Sf. Maria“ Hospital, Internal Medicine and Rheumatology Department, Bucharest, Romania, Balanescu Andra ,   “Carol Davila“ University of Medicine and Pharmacy, Bucharest, Romania,   “Sf. Maria“ Hospital, Internal Medicine and Rheumatology Department, Bucharest, Romania, Bojinca Violeta ,   “Carol Davila“ University of Medicine and Pharmacy, Bucharest, Romania,   “Sf. Maria“ Hospital, Internal Medicine and Rheumatology Department, Bucharest, Romania, Berghea Florian ,   “Carol Davila“ University of Medicine and Pharmacy, Bucharest, Romania,   “Sf. Maria“ Hospital, Internal Medicine and Rheumatology Department, Bucharest, Romania, Groseanu Laura ,   “Carol Davila“ University of Medicine and Pharmacy, Bucharest, Romania,   “Sf. Maria“ Hospital, Internal Medicine and Rheumatology Department, Bucharest, Romania, Constantinescu Cosmin ,   “Carol Davila“ University of Medicine and Pharmacy, Bucharest, Romania,   “Sf. Maria“ Hospital, Internal Medicine and Rheumatology Department, Bucharest, Romania, Borangiu Andreea ,   “Carol Davila“ University of Medicine and Pharmacy, Bucharest, Romania,   “Sf. Maria“ Hospital, Internal Medicine and Rheumatology Department, Bucharest, Romania, Daia-Iliescu Sanziana ,   “Carol Davila“ University of Medicine and Pharmacy, Bucharest, Romania,   “Sf. Maria“ Hospital, Internal Medicine and Rheumatology Department, Bucharest, Romania, Mazilu Diana ,   “Carol Davila“ University of Medicine and Pharmacy, Bucharest, Romania,   “Sf. Maria“ Hospital, Internal Medicine and Rheumatology Department, Bucharest, Romania, Negru Magda ,   “Carol Davila“ University of Medicine and Pharmacy, Bucharest, Romania,   “Sf. Maria“ Hospital, Internal Medicine and Rheumatology Department, Bucharest, Romania, Cobilinschi Claudia ,   “Carol Davila“ University of Medicine and Pharmacy, Bucharest, Romania,   “Sf. Maria“ Hospital, Internal Medicine and Rheumatology Department, Bucharest, Romania, Predeteanu Denisa ,   “Carol Davila“ University of Medicine and Pharmacy, Bucharest, Romania,   “Sf. Maria“ Hospital, Internal Medicine and Rheumatology Department, Bucharest, Romania, Ionescu Ruxandra ,   “Carol Davila“ University of Medicine and Pharmacy, Bucharest, Romania,   “Sf. Maria“ Hospital, Internal Medicine and Rheumatology Department, Bucharest, Romania
Published: July 2022

Systemic Lupus Erythematosus is the hallmark of autoimmune diseases, being characterized by multiple organ involvements and immune abnormalities, amongst which the presence of antiphospholipid antibodies with or without specific clinical manifestations (vascular thromboses and pregnancy morbidities) has a significant impact on the disease course, both short and long term, causing the accumulation of irreversible damage. This study evaluates the aforementioned impact, highlighting the importance of very early screening for these antibodies.